SKYE
Ticker
Skye Bioscience, Inc.
SKYESKYE has 6 disclosed filings on Paydirt over the past 24 months from 5 corporate insiders: 0 purchases and 6 sales, 1 filed past the deadline. Filers took a median of 1 day from execution to disclosure, and the most recent trade was executed Aug 22 2025 and filed Aug 22 2025. The most active filer was Kaitlyn Arsenault with 2 filings.
Add to watchlistFilings, 24m
6
0 buys · 6 sells · 1 late
Traders, 24m
5
5 insiders
Volume, 24miDollar value disclosed in the window
$2.8M
estimated for Congress, as filed for insiders
Median delay
1d
execution to disclosure
Last traded
Aug 22 2025
Filed Aug 22 2025
ADViAverage daily dollar volume
–
not on file
Share price · 12M
$0.60 (-84.6%)
Adjusted for splits and dividends.
Volume by month
Buys $0
Sells $2.8M
Estimated for Congress, as filed for insiders · by filing month · past 24 months
Who filed
KA
Kaitlyn Arsenault
Chief Financial Officer
2 filings
PD
Punit Dhillon
Chief Executive Officer
1 filing
PG
Paul A. Grayson
Director
1 filing
SR
Scott M Rocklage
10% owner
1 filing
ASRecent filings
Scott M RocklageSALE
10% owner
$770K222,621 sh across 2 lots
Exec Aug 21 2025
Filed Aug 22 2025 · 5:30 PM ET Andrew J. SchwabSALE Director $770K
222,621 sh across 2 lots
Exec Aug 21 2025
Filed Aug 22 2025 · 5:30 PM ET Kaitlyn ArsenaultSALE Chief Financial Officer $215K
43,026 sh × $4.99
Exec Nov 18 2024
Filed Feb 28 2025 · 5:30 PM ET † Paul A. GraysonSALE Director $430K
86,244 sh × $4.99
Exec Nov 18 2024
Filed Nov 19 2024 · 5:30 PM ET Punit DhillonSALE Chief Executive Officer $412K
82,546 sh × $4.99
Exec Nov 18 2024
Filed Nov 19 2024 · 5:30 PM ET Kaitlyn ArsenaultSALE Chief Financial Officer $216K
43,206 sh × $4.99
Exec Nov 18 2024
Filed Nov 19 2024 · 5:30 PM ET 5AM Ventures VII, L.P.SALE 10% owner –
251,060 sh across 2 lots · price not plausible
Exec Sep 11 2024
Filed Sep 13 2024 · 5:30 PM ET Andrew J. SchwabSALE Director –
251,060 sh across 2 lots · price not plausible
Exec Sep 11 2024
Filed Sep 13 2024 · 5:30 PM ET